Oscar Health Analysts Upgrade Estimates Following Earnings Miss

Oscar Health, Inc. (NYSE:OSCR) missed earnings expectations with its latest annual results, with revenues at $12b and statutory earnings at a loss of $1.69. Analysts have upgraded their estimates, forecasting revenues of $16.7b in 2026, a 43% improvement from the previous year, and a statutory profit of $0.34 per share. The consensus price target remains at $15.40, but there is a wide range of possible valuations among analysts.